A regional study in England demonstrated a frequency for CCD of 1 in 250.000 individuals [17], while another study in Japan revealed that carrier frequency for heterozygous RYR1 mutations in that population could be as high as 1 in 2000 [13]. Here, RYR1 is linked to central core myopathy.